Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients
Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome. The use pattern for these prescription cannabinoids in the USA i...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2023-06-01
|
| Series: | Medical Cannabis and Cannabinoids |
| Subjects: | |
| Online Access: | https://beta.karger.com/Article/FullText/531058 |